Danai Dima
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
Papers in
- Hematology 63
- Multiple Myeloma Research and Treatments 52
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Oncology 48
- CAR-T cell therapy research 43
- Viral-associated cancers and disorders 2
- Co-authors
- Fauzia Ullah (22 shared papers)Jack Khouri (30 shared papers)Faiz Anwer (26 shared papers)Shahzad Raza (20 shared papers)Joshua Dower (6 shared papers)Jason Neil Valent (14 shared papers)Raymond L. Comenzo (3 shared papers)Al-Ola A. Abdallah (10 shared papers)
- Journals
- Transplantation and Cellular Therapy (20 papers)Blood (14 papers)Blood Cancer Journal (11 papers)Cancers (6 papers)Blood Advances (5 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Danai Dima
92 papers receiving 1.4k citations
Danai Dima's Hit Papers
Peers
Comparison fields: 5 of 60
- Hematology 818
- Oncology 692
- Internal Medicine 12
- Toxicology 13
- Pathology and Forensic Medicine 41
Countries citing papers authored by Danai Dima
This map shows the geographic impact of Danai Dima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danai Dima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danai Dima more than expected).
Fields of papers citing papers by Danai Dima
This network shows the impact of papers produced by Danai Dima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danai Dima. The network helps show where Danai Dima may publish in the future.
Co-authors
The 25 scholars most cited alongside Danai Dima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium Hit paper breakdown → | 2023 | 234 |
| 2 | 2023 | 93 | |
| 3 | Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma Hit paper breakdown → | 2024 | 93 |
| 4 | 2023 | 68 | |
| 5 | 2024 | 59 | |
| 6 | 2023 | 51 | |
| 7 | 2022 | 46 | |
| 8 | 2023 | 46 | |
| 9 | 2023 | 40 | |
| 10 | 2024 | 40 | |
| 11 | 2020 | 38 | |
| 12 | 2023 | 38 | |
| 13 | 2023 | 34 | |
| 14 | 2024 | 34 | |
| 15 | 2025 | 31 | |
| 16 | 2024 | 30 | |
| 17 | 2023 | 29 | |
| 18 | 2024 | 25 | |
| 19 | 2023 | 23 | |
| 20 | 2023 | 20 |
About Danai Dima
Danai Dima is a scholar working on Hematology, Oncology, Immunology, Pathology and Forensic Medicine and Emergency Medicine, having authored 105 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (52 papers), CAR-T cell therapy research (43 papers), Acute Myeloid Leukemia Research (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Hematopoietic Stem Cell Transplantation (4 papers), Complement system in diseases (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Hematology (818 citations), Oncology (692 citations), Internal Medicine (12 citations), Toxicology (13 citations) and Pathology and Forensic Medicine (41 citations). Danai Dima has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Fauzia Ullah, Jack Khouri, Faiz Anwer, Shahzad Raza, Joshua Dower, Jason Neil Valent, Raymond L. Comenzo, Al-Ola A. Abdallah, Hamza Hashmi and Cindy Varga. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Cancer Journal, Cancers and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.